Thursday, January 18, 2024 episode artwork

EPISODE · Jan 18, 2024 · 8 MIN

Thursday, January 18, 2024

from The Gist Healthcare Podcast

Venture capital firm General Catalyst’s healthcare arm plans to purchase Akron, Ohio-based Summa Health, and turn it into a for-profit system. CMS issues a final rule that aims to streamline health insurer prior authorizations. And, the FDA approves a groundbreaking CRISPR treatment for a second blood disease. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Venture capital firm General Catalyst’s healthcare arm plans to purchase Akron, Ohio-based Summa Health, and turn it into a for-profit system. CMS issues a final rule that aims to streamline health insurer prior authorizations. And, the FDA approves a groundbreaking CRISPR treatment for a second blood disease. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Thursday, January 18, 2024

0:00 8:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 8 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on January 18, 2024.

What is this episode about?

Venture capital firm General Catalyst’s healthcare arm plans to purchase Akron, Ohio-based Summa Health, and turn it into a for-profit system. CMS issues a final rule that aims to streamline health insurer prior authorizations. And, the FDA approves...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!